ReviewPublic health challenges2026
Infectious Disease Response in Tanzania: Enhanced Strategies From the 2023 to 2025 Marburg Outbreaks.
Review in Public health challenges, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infectious Disease Response in Tanzania: Enhanced Strategies From the 2023 to 2025 Marburg Outbreaks.Public health challenges · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2023 Marburg virus disease (MVD) outbreak in Tanzania, which resulted in nine confirmed cases and six deaths (case fatality rate [CFR]: 66.7%), served as a critical stress test of the national health system, revealing significant gaps in outbreak preparedness across surveillance, laboratory capacity, and infection prevention and control (IPC). This narrative review examines how Tanzania's public health response evolved between the 2023 and subsequent 2025 outbreak and assesses how response strategies changed between the two outbreaks. The 2025 outbreak was limited to two confirmed cases with no further transmission, a marked contrast to the 2023 outbreak. Between the two outbreaks, Tanzania implemented several critical interventions, including expansions of PCR diagnostic capacity, integration of electronic tracing modules, and public health communication strategies. This review synthesizes publicly available reports from the World Health Organization (WHO), Africa Centers for Disease Control and Prevention (Africa CDC), the Tanzanian Ministry of Health, and peer-reviewed literature, and analysis focuses on three major response domains: infectious disease surveillance, IPC, and public health education as key factors associated with Tanzania's progress. The rapid containment of the 2025 outbreak suggests meaningful progress in Tanzania's public health capabilities and the need for continued, sustained investment in integrated surveillance systems and IPC infrastructure to maintain resilience against future outbreaks. Tanzania's adaptation and multi-level interventions between 2023 and 2025 provide a model for regional health security in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.